We analyzed the association between APC mutation and immunotherapy outcome using a cohort of CRC patients treated with ICIs showing that they had significantly shorter OS time after immunotherapy than that of APC WT patients (Fig. 5h). The gene discussed is APC; the disease is colorectal carcinoma.